Showing results (11-20 of 315) with videos related to
Sort By:
Pageof 32
Atherosclerosis|October 31, 2006
Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidationMaren Luchtefeld, Nele Bandlow, Uwe J F Tietge, et al.Hypertension (Dallas, Tex. : 1979)|October 7, 2009
Hepatocyte gp130 deficiency reduces vascular remodeling after carotid artery ligationGustavo Salguero, Harald Schuett, Joanna Jagielska, et al.Vascular Pharmacology|December 16, 2018
Variety matters: Diverse functions of monocyte subtypes in vascular inflammation and atherogenesisAnn-Kathrin Vlacil, Jutta Schuett, Bernhard Schieffer, et al.Biochemical and Biophysical Research Communications|January 27, 2005
Angiotensin II induces MMP-2 in a p47phox-dependent mannerMaren Luchtefeld, Karsten Grote, Christina Grothusen, et al.Thrombosis and Haemostasis|August 5, 2009
How much is too much? Interleukin-6 and its signalling in atherosclerosisHarald Schuett, Maren Luchtefeld, Christina Grothusen, et al.Circulation|October 6, 2010
Chemokine receptor 7 knockout attenuates atherosclerotic plaque developmentMaren Luchtefeld, Christina Grothusen, Andreas Gagalick, et al.Circulation Research|March 3, 2007
Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarctionCarola Doerries, Karsten Grote, Denise Hilfiker-Kleiner, et al.Journal of Vascular Research|February 11, 2010
Mechanical stress modulates SOCS-1 expression in human vascular smooth muscle cellsMarc Dangers, Julia Kiyan, Karsten Grote, et al.The Journal of Allergy and Clinical Immunology|December 26, 2024
Long COVID: Pathophysiology, current concepts, and future directionsChrysanthi Skevaki, Charalampos D Moschopoulos, Paraskevi C Fragkou, et al.Circulation Research|September 22, 2007
Systemic deficiency of the MAP kinase-activated protein kinase 2 reduces atherosclerosis in hypercholesterolemic miceKumaravelu Jagavelu, Uwe J F Tietge, Matthias Gaestel, et al.Pageof 32